Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2009 · 13 citations · 17 references
MedicineEndocrinologyDiabetologyHuman NutritionLipid BiochemistryCardiovascular DiseaseCardiovascular EpidemiologyDiabetes ControlDiabetes MellitusLipid DisordersLipoprotein AnalysisAnti-glutamic Acid Decarboxylase AntibodiesApolipoprotein B-containing LipoproteinsCardiovascular Disease PrevalenceDiabetic DyslipidemiaGlutamic Acid Decarboxylase AntibodiesHigh-density Lipoprotein Cholesterol MeasurementLipid Profile AnalysisMedian Age
BACKGROUND: Apolipoproteins B (apoB) and AI (apoAI) are strong predictors of cardiovascular disease (CVD). We describe apolipoprotein distributions and their associations with lipids and diabetes subtype in diabetic young adult South Asians. METHODS: In 995 subjects with diabetes, we measured fasting total cholesterol (TC), high-density lipoprotein cholesterol (HDLC), triglycerides (TG), apoB and apoAI, glycosylated haemoglobin (HbA1c) and glutamic acid decarboxylase antibodies (GADA). Low-density lipoprotein cholesterol (LDLC) and non-HDLC (NHDLC) were calculated. We compared values in subjects aged 15-50 y from the United States National Health and Nutrition Examination Survey (NHANES). RESULTS: Median age and duration of diabetes were 38 (range 14-45) and 4 (0-24) y. Men had significantly higher TC, TG, NHDLC, TC/HDLC, apoB/AI and NHDLC/apoB, and lower apoAI than women. Compared with the reference group, patients with type 1 diabetes had lower TG, apoB:apoAI and HDLC:apoAI, and higher HDLC and apoAI. Patients with type 2 diabetes had higher TG, TC, LDLC, NHDLC, TC:HDL, apoB, apoAI and apoB:apoAI, and lower HDLC, LDLC:apoB and HDLC:apoAI. Among patients with type 2 diabetes, 54% had high apoB (>1.2 g/L) and 33% also had high TG (>1.5 mmol/L). Measures of obesity (body mass index and waist circumference) were weakly correlated with lipid and apoprotein parameters, suggesting a modest contribution to dyslipidaemia. CONCLUSIONS: A large proportion of young adult Sri Lankan patients with type 2 diabetes has a low LDLC:apoB and high apoB and/or TG, suggesting that these patients are at increased risk of CVD.
17
Diabetes and Cardiovascular Disease
William B. Kannel · JAMA · 1979 · 2.8K citations
Jacqueline de Graaf, Heidi L.M. Hak-Lemmers, M.P.C. Hectors et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1991 · 718 citations